MHLW Approves Abbott’s Humira To Be Distributed By Eisai In Japan
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In contrast to wide criticisms about long drug lags in Japan, the Ministry of Health, Labor and Welfare has approved Abbott's rheumatoid arthritis antibody drug Humira (adalimumab) to be distributed by Eisai in Japan, the two companies announced June 17